Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006300 · ClinicalTrials.gov registry record
Oral Manifestations of Aplastic Anemia
A clinical trial of Aplastic Anemia, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT00006300 is a study of Aplastic Anemia that has completed, run by National Institute of Dental and Craniofacial Research (NIDCR). The registered enrollment target is 146 participants, above the 36-participant average among 23 other Aplastic Anemia trials with a reported enrollment target (306% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00006300, a study of Aplastic Anemia, has completed, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are threefold: 1) to evaluate the prevalence and risks of oral complications in patients with aplastic anemia; 2) to evaluate if oral problems in these patients can predict their response to treatment; and 3) to review complications of dental treatment in these patients in order to establish treatment guidelines. This study will be performed through a review of medical charts of 79 patients with aplastic anemia and 67 patients with schizophrenia who were treated at the National Institutes of Health Dental Clinic between 1993 and 1999. The schizophrenia patients will serve as a control population. Demographic, clinical and radiographic information will be collected for all patients. Additional data collected only for aplastic anemia patients will include medical therapy, disease duration, blood cell counts, oral problems that developed during treatment and treatment response.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Dental And Craniofacial Research (NIDCR) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2000-04 |
| Est. Completion | 2002-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006300
The ClinicalTrials.gov registry entry for NCT00006300 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 36-participant average among 23 other Aplastic Anemia trials with a reported enrollment target (306% higher). The listed sponsor is National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aplastic Anemia appearing as the primary indexed condition, and to 0 interventions.
NCT00006300 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00006300 about?
NCT00006300 is a clinical study titled "Oral Manifestations of Aplastic Anemia". The purposes of this study are threefold: 1) to evaluate the prevalence and risks of oral complications in patients with aplastic anemia; 2) to evaluate if oral problems in these patients can predict their response to treatment; and 3) to review complications of dental treatment in these patients in...
What is the current status of trial NCT00006300?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2000-04. Estimated completion is 2002-04.
What conditions does trial NCT00006300 study?
This clinical trial studies the following conditions: Aplastic Anemia.
Who is sponsoring clinical trial NCT00006300?
This trial is sponsored by National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006300 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aplastic Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
-
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
RECRUITING · Phase 2
-
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RECRUITING · Early Phase 1
-
Two Step Haplo With Radiation Conditioning
RECRUITING · Phase 2
-
Umbilical Cord Blood Transplantation From Unrelated Donors
RECRUITING
-
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.